BioNTech SE (BNTX) Tops Q1 EPS by 20c, provides guidance

BioNTech SE (NASDAQ: BNTX) reported Q1 EPS of (EUR1.95), EUR0.20 better than the analyst estimate of (EUR2.15). Revenue for the quarter came in at EUR118.1 million versus the consensus estimate of EUR185.6 million.

GUIDANCE:

BioNTech SE sees FY2026 revenue of EUR2-2.3 billion, versus the consensus of EUR2.185 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Alphabet added to Dow Jones Industrial Average, Verizon dropped
• Cboe launches binary options suite tied to Mini-S&P 500 Index